Farther Finance Advisors’s Verona Pharma VRNA Stock Holding History

Farther Finance Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,007	Closed	-$107K	–	5598
2025 Q3	$107K	Buy	1,007 +7	+0.7%	+$731	﹤0.01%	2005
2025 Q2	$94.6K	Buy	+1,000	New	+$74K	﹤0.01%	1786

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Farther Finance Advisors's VRNA Position: Q4 2025 in Review

Farther Finance Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,007 shares — an estimated $107K sold.

Farther Finance Advisors first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $107K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Farther Finance Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Farther Finance Advisors sold 1,007 Verona Pharma shares in Q4 2025, an estimated $107K.
Farther Finance Advisors first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Farther Finance Advisors's Verona Pharma position peaked at $107K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.